Cargando…
A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2− early breast cancer
To make an optimal treatment decision for early stage breast cancer, it is important to identify risk of recurrence. Here, we developed and validated a new prognostic model for predicting the risk of distant metastasis in patients with pN0-N1, hormone receptor-positive, HER2-negative (HR+/HER2−) bre...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368569/ https://www.ncbi.nlm.nih.gov/pubmed/28350001 http://dx.doi.org/10.1038/srep45554 |